Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

Osteopore Ltd

Healthcare AU OSX

0.015AUD
0.002(15.38%)

Last update at 2025-06-13T06:10:00Z

Day Range

0.010.01
LowHigh

52 Week Range

0.010.08
LowHigh

Fundamentals

  • Previous Close 0.01
  • Market Cap2.43M
  • Volume1668195
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.46522M
  • Revenue TTM2.76M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 2.30M
  • Diluted EPS TTM-0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.19522M -3.62090M -1.94589M -2.38234M -0.84720M
Minority interest - - - - -
Net income -4.21560M -3.92865M -2.68796M -2.40043M -0.84720M
Selling general administrative 4.52M 4.20M 3.28M 1.53M 1.58M
Selling and marketing expenses 1.01M 0.50M 0.33M 0.21M -
Gross profit 1.36M 1.10M 1.68M 0.29M 0.70M
Reconciled depreciation 0.22M 0.23M 0.17M 0.07M -
Ebit -4.17485M -3.60460M -1.92828M -2.36671M -0.87805M
Ebitda -3.95663M -3.37913M -1.76240M -2.29414M -
Depreciation and amortization 0.22M 0.23M 0.17M 0.07M -
Non operating income net other - - - - -
Operating income -4.17485M -3.60460M -1.92828M -2.36671M -0.87805M
Other operating expenses 6.17M 5.23M 4.32M 2.78M 0.00246M
Interest expense 0.02M 0.02M 0.02M 0.02M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M -
Interest income 0.02M 0.02M 0.02M 0.02M -
Net interest income -0.02038M -0.01630M -0.01760M -0.01563M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.02M 0.31M 0.74M 0.02M -
Total revenue 1.78M 1.40M 2.23M 0.41M 0.91M
Total operating expenses 5.75M 4.93M 3.77M 2.66M 1.79M
Cost of revenue 0.42M 0.30M 0.55M 0.12M 0.21M
Total other income expense net -0.02038M -0.01630M -0.01760M -0.01563M 0.03M
Discontinued operations - - - - -
Net income from continuing ops -4.19522M -3.62090M -1.94589M -2.38234M -0.84720M
Net income applicable to common shares -4.19522M -3.62090M -1.94589M -2.38234M -0.84720M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 3.32M - 3.62M 6.01M 10.25M
Intangible assets 0.46M - - - -
Earning assets - - - - -
Other current assets 0.65M -1.11500M 0.71M 0.29M 0.26M
Total liab 2.88M - 1.51M 0.63M 1.25M
Total stockholder equity 0.43M - 2.11M 5.37M 9.00M
Deferred long term liab - - - - -
Other current liab 0.06M - 0.07M 0.03M 0.06M
Common stock 32.60M - 27.01M 26.07M 26.07M
Capital stock - - 27.01M 26.07M 26.07M
Retained earnings -17.95831M - -10.90219M -7.94913M -4.32823M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.64M 1.11M 2.16M 4.93M 9.03M
Cash and equivalents - - 0.00540M - -
Total current liabilities 2.77M - 1.48M 0.56M 1.25M
Current deferred revenue - - - - -
Net debt 0.69M -1.11500M -2.09076M -4.82420M -8.57302M
Short term debt 1.22M - 0.05M 0.08M 0.45M
Short long term debt - - - - 0.43M
Short long term debt total 1.33M - 0.07M 0.11M 0.45M
Other stockholder equity - - -0.20141M -12.74412M -12.74156M
Property plant equipment - - 0.47M 0.59M 0.51M
Total current assets 2.53M - 3.15M 5.42M 9.74M
Long term investments - - - - -
Net tangible assets - - 2.05M 5.37M 9.00M
Short term investments - - - 0.20M 0.02M
Net receivables 0.86M - 0.87M 0.40M 0.31M
Long term debt - - - - -
Inventory 0.38M - 0.28M 0.20M 0.15M
Accounts payable 1.49M - 1.37M 0.45M 0.74M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -14.20741M - -14.00300M -12.74412M -12.74156M
Additional paid in capital - - - - -
Common stock total equity - - - - 26.07M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 0.18M -
Deferred long term asset charges - - - - -
Non current assets total 0.78M - 0.47M 0.59M 0.51M
Capital lease obligations - - 0.07M 0.11M 0.03M
Long term debt total - - 0.03M 0.07M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.06398M -0.19462M -0.38104M 0.41M -
Change to liabilities 0.87M -0.27485M 0.02M -0.06491M 0.13M
Total cashflows from investing activities -0.06398M -0.19462M -0.38104M 0.41M -0.06475M
Net borrowings -0.04868M -0.48588M -0.09944M -0.62472M -0.58619M
Total cash from financing activities 0.84M -0.48588M 7.84M 4.64M 0.91M
Change to operating activities -0.37718M -0.11152M -0.22697M -0.08098M 0.16M
Net income -4.21560M -3.62090M -1.96349M -2.39797M -0.84720M
Change in cash -3.19595M -4.49684M 5.73M 3.29M 0.53M
Begin period cash flow 4.53M 9.03M 3.29M 0.00000M -
End period cash flow 1.33M 4.53M 9.03M 3.29M 0.00000M
Total cash from operating activities -3.99738M -3.80563M -1.75772M -1.74876M -0.32228M
Issuance of capital stock 0.94M - 8.50M 5.50M -
Depreciation 0.22M 0.23M 0.17M 0.07M 0.08M
Other cashflows from investing activities - - 0.00000M 0.49M 0.00000M
Dividends paid - - - - -
Change to inventory -0.07754M -0.05024M -0.12785M 0.02M -0.00647M
Change to account receivables -0.42998M -0.05706M 0.26M -0.14719M -0.12245M
Sale purchase of stock -0.05407M 0.00000M -0.56339M -0.24175M -
Other cashflows from financing activities -0.04868M -0.04294M -0.04106M -0.02927M -0.24175M
Change to netincome 0.00072M 0.08M 0.10M 0.83M 0.29M
Capital expenditures 0.06M 0.19M 0.38M 0.08M 0.06M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.02037M -0.52761M -0.08793M -0.26946M -
Stock based compensation - - - - -
Other non cash items 4.00M 3.40M 1.78M 2.38M -
Free cash flow -4.06135M -4.00025M -2.13877M -0.07834M -

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OSX
Osteopore Ltd		 0.002 15.38% 0.01 - - 0.88 7.93 1.06 -2.1957
RMD
Resmed Inc DRC		 -0.33 0.85% 38.52 28.17 24.27 11.35 6.68 7.31 20.92
FPH
Fisher & Paykel Healthcare Corporation Limited		 -0.39 1.14% 33.92 58.07 51.55 9.99 11.41 16.75 32.77
ANN
Ansell Ltd		 -0.34 1.09% 30.72 24.66 22.94 2.43 1.55 1.89 13.41
NAN
Nanosonics Ltd		 -0.01 0.23% 4.42 88.60 62.50 7.31 7.02 6.42 42.28

Reports Covered

Stock Research & News

View All

Profile

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures and trades medical implants; sells medical devices; provides technology services; and engages in research and development activities. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

Osteopore Ltd

2 Tukang Innovation Grove #09-06/07, Singapore, Singapore, 6000

Key Executives

Name Title Year Born
Mr. Kei Wei Leong Exec. Chairman 1976
Mr. Khoon Seng Goh Chief Exec. Officer NA
Dr. Jing Lim COO & CTO NA
Ms. Deborah Ho AGIA, B.Com. Company Sec. 1988
Mr. Kei Wei Leong Executive Chairman 1976
Dr. Jing Lim CEO & CTO NA
Mr. Khoon Seng Goh Global Marketing Director NA
Ms. Shu Ning Voon Financial Controller NA
Ms. Kellie Davis Joint Company Secretary NA
Mr. Kei Wei Leong Executive Chairman 1976

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.